| Title: ICI 176,334: a novel non-steroidal, peripherally selective antiandrogen. | |||
| Title Abreviation: J Endocrinol | Date of Pub: 1987 Jun | ||
| Author: Furr BJ; Valcaccia B; Curry B; Woodburn JR; Chesterson G; Tucker H; | |||
| Issue/Part/Supplement: 3 | Volume Issue: 113 | Pagination: R7-9 | |
| MESH Headings: Androgen Antagonists (ME/*PD); Anilides (*PD); Animal; LH (BL); Male; Prostate (DE/ME); Rats; Receptors, Androgen (ME); Seminal Vesicles (DE); Testosterone (BL); -RN-; | |||
| Journal Title Code: I1J | Publication Type: JOURNAL ARTICLE | ||
| Date of Entry: 871013N | Entry Month: 8712 | ||
| Country: ENGLAND | Index Priority: 1 | ||
| Language: Eng | Unique Identifier: 87310192 | ||
| Unique Identifier: 87310192 | ISSN: 0022-0795 | ||
| Abstract: Pure antiandrogens, like flutamide, antagonize androgen action both peripherally and centrally at the hypothalamic-pituitary axis, which leads to an increase in LH and testosterone secretion. A new non-steroidal antiandrogen ICI 176,334 [2RS)-4'-cyano-3-(4-fluorophenylsulphonyl)-2-hydroxy-2-methyl-3'- trifluoromethyl)propion-anilide) has now been discovered which causes regression of the accessory sex organs but does not increase serum concentrations of LH and androgens. ICI 176,334 binds to rat prostate androgen receptors with an affinity around fourfold that of hydroxyflutamide. When administered s.c. concurrently with testosterone propionate (200 micrograms/kg) for 7 days to immature castrated rats, ICI 176,334 (10 mg/kg) significantly (P less than 0.001) inhibited growth of the seminal vesicles and ventral prostate gland. Oral administration of ICI 176,334 at doses of 1, 5 and 25 mg/kg for 14 days to adult rats caused a dose-related reduction in accessory sex organ weights but had no effect on the testes. None of these doses caused a significant increase in serum LH and testosterone. Flutamide was around fourfold less potent and significantly increased serum LH and testosterone at the higher doses. ICI 176,334 was well tolerated. ICI 176,334 should, therefore, prove useful for the treatment of androgen-responsive benign and malignant diseases. | |||
| Abstract By: Author | |||
FACTS ABOUT HAIR TRANSPLANTS:
- Hair transplants are well suited for a majority of candidates
- Follicular unit hair transplants provide natural results
- The only proven permanent solution for hairloss today
Thinking about a
Transplant?
Transplants are safer and
more effective than ever.
Find a hair loss doctor.
Enter you Zip/Postal Code:
» Sponsors
SuperGrow Home Laser
Want faster results? Our new Laser Dome hair laser provides superior coverage and is easy to use. Fast results GUARANTEED!
- Thicker Fuller Hair
- Save Thousands of $$$
- Easiest Laser to Use
Propecia
is used for the treatment of male pattern hair loss (androgenic alopecia) in men. The once a day, FDA approved pill for hair loss.
![]()
Regenepure Shampoo
Healthier, fuller results begin with just one application with the best ingredients for your hair.
- No Lauryl or Laureth Sulfates
- Sulfate and Paraben Free
- Recommended by Physicians
ProMox
Up to 75% more effective on both front and top of the scalp than regular Minoxidil
- Topical Finasteride
- Retin-A and Azeleic Acid
- Spray, Foam or Cream
Avodart
provides superior blocking of the hormone that causes hair loss than Propecia.
![]()
Viagra
Has helped many men who have erectile dysfunction (ED) problems.
![]()








